Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction

Verschuren, J.J.W.; Boden, H.; Wessels, J.A.M.; Hoeven, B.L. van der; Trompet, S.; Heijmans, B.T.; ... ; Jukema, J.W. (2013)

Article / Letter to editor

• Pharmacogenetics
• Antiplatelet therapy
• ST-segment elevation myocardial infarction
• Treatment outcome
• Cytochrome P450 2C19
• Cyclooxygenase 1

• All authors: Verschuren, J.J.W.; Boden, H.; Wessels, J.A.M.; Hoeven, B.L. van der; Trompet, S.; Heijmans, B.T.; Putter, H.; Guchelaar, H.J.; Schalij, M.J.; Jukema, J.W.
• Date: 2013-09-10
• Journal: International Journal of Cardiology
• Volume: 167
• Issue: 6
• Pages: 2882 - 2888
• DOI: doi:10.1016/j.ijcard.2012.07.020